Insider buying
~$756K189K sh @ $4.00
Traded Nov 13 · filed 5 days later
Since the trade +28.8% · S&P 500 −8.6% · to Nov 20
Bought 76% below the 52-week high, RSI 44, 28% under its 200-day average, 29 points behind the S&P 500 over 3 months
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Checked for new insider filings 2 h ago
Guides: What is an SEC Form 4 · the transaction codes · who has to file · 10b5-1 plans
Worth a look: purchases of $10K+ and sales of $250K+ not reported under a pre-arranged trading plan.
Insider buying
Traded Nov 13 · filed 5 days later
Since the trade +28.8% · S&P 500 −8.6% · to Nov 20
Bought 76% below the 52-week high, RSI 44, 28% under its 200-day average, 29 points behind the S&P 500 over 3 months
A major shareholder of Clearone paid $756K out of pocket for Clearone shares. It was the first purchase in 8 months. Shares held went up 10% with this purchase.
Lately at Clearone: the stock rose 46% in one session on Nov 18 around a Form 8-K; it signed an important agreement on Nov 17; the stock is up 144% in 30 days.
Insider buying
Traded Nov 17 · filed 1 day later
Since the trade −2.6% · S&P 500 −5.8% · to Nov 20
Bought within 4% of the 52-week low, RSI 38, 35% under its 200-day average, 34 points behind the S&P 500 over 3 months
The CFO of MP Materials paid $92K out of pocket for MP Materials shares. 2 other people at MP Materials bought some too, in the same month.
Lately at MP Materials: it reported its results on Nov 5; the stock is down 14% in 30 days; insiders made 8 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
3 days before resultsTraded Nov 16 · filed 2 days later
Since the trade −0.9% · S&P 500 −6.8% · to Nov 20
Bought 29% below the 52-week high, RSI 63, 14% above its 200-day average, 61 points ahead of the S&P 500 over 3 months
A major shareholder of San Juan Basin Royalty Trust paid $1.1M out of pocket for San Juan Basin Royalty Trust shares.
Lately at San Juan Basin Royalty Trust: the stock rose 17% in one session on Nov 10; it reported its results on Nov 19; the stock is up 29% in 30 days.
Traded Nov 17, 2026 · largest single transaction ~$647K
Lately at Atlassian: the stock fell 16% in one session on Nov 6 around a company release; it changed a top executive or board member on Nov 5; the stock is down 40% in 30 days.
Nov 17, 2026~$647K · 4,400 sh @ $147.00
DetailsOfficial recordNov 17, 2026~$213K · 1,500 sh @ $142.02
DetailsOfficial recordInsider buying
Traded Nov 16 · filed 2 days later
Since the trade −5.0% · S&P 500 −6.8% · to Nov 20
Bought at the 52-week low, RSI 30, 49% under its 200-day average, 49 points behind the S&P 500 over 3 months
The CEO of International Tower Hill Mines paid $74K out of pocket for International Tower Hill Mines shares. Shares held went up 51% with this purchase.
Lately at International Tower Hill Mines: the stock is down 45% in 30 days; insiders made 3 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Largest insider buy since 2022Traded Nov 16 · filed 2 days later
Since the trade −4.3% · S&P 500 −6.8% · to Nov 20
Bought 66% below the 52-week high, RSI 53, 18% under its 200-day average
A major shareholder of Pasithea Therapeutics paid $291K out of pocket for Pasithea Therapeutics shares. Shares held went up 14% with this purchase.
Lately at Pasithea Therapeutics: the stock is 67% below its 12-month high; insiders made 3 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Traded Nov 16, 2026 · largest single transaction ~$67K
Lately at Franklin BSP Realty Trust, Inc.: it reported its results on Oct 28; the stock is 43% below its 12-month high; insiders made 5 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Nov 16, 2026~$67K · 3,984 sh @ $16.90
DetailsOfficial recordNov 16, 2026~$31K · 1,807 sh @ $16.90
DetailsOfficial recordInsider buying
Open-market purchases, traded Nov 16 – Nov 17, 2026. Each amount is that person's own.
Lately at Hawkeye 360: the stock rose 24% in one session on Nov 13 around a company release; it reported its results on Nov 12; the stock is up 36% in 30 days.
Insider buying
First insider buy since Sep 2025Traded Nov 18 · filed the same day
Since the trade −0.7% · S&P 500 −5.5% · to Nov 20
Bought 6% below the 52-week high, RSI 63, 19% above its 200-day average
Cg Oncology's Chief Commercial Officer paid $299K out of pocket for Cg Oncology shares. 1 other person at Cg Oncology bought some too, in the same month. It was the first purchase in over a year.
Lately at Cg Oncology: the stock rose 14% in one session on Nov 16 around a company release; it reported its results on Nov 6; the stock is up 28% in 30 days.
Insider buying
Their first buy on recordTraded Nov 18 · filed the same day
Since the trade −1.9% · S&P 500 −5.5% · to Nov 20
Bought within 3% of the 52-week low, RSI 29, 22% under its 200-day average, 12 points behind the S&P 500 over 3 months
A California Resources director paid $100K out of pocket for California Resources shares. 1 other person at California Resources bought some too, in the same month. It was the first purchase in over a year.
Lately at California Resources Corporation: it reported its results on Nov 2; the stock is down 18% in 30 days; insiders made 2 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Open-market purchases, traded Nov 16, 2026. Each amount is that person's own.
Lately at Once Upon A Farm, Pbc: the stock rose 21% in one session on Nov 16 with press coverage; it reported its results on Nov 12; the stock is down 24% in 30 days.
Insider buying
Their largest buy since 2011Traded Nov 18 · filed the same day
Since the trade −0.7% · S&P 500 −5.5% · to Nov 20
Bought within 1% of the 52-week low, RSI 34, 9% under its 200-day average, 10 points behind the S&P 500 over 3 months
An Umh Properties director paid $14K out of pocket for Umh Properties shares. 2 other people at Umh Properties bought some too, in the same month. Shares held went up 100% with this purchase.
Lately at Umh Properties: it reported its results on Nov 2; the stock is down 7% in 30 days; insiders made 4 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
3 insiders in a week, 3rd time since 2022Traded Nov 16 · filed 2 days later
Since the trade +6.6% · S&P 500 −6.8% · to Nov 20
Bought at the 52-week low, RSI 30, 41% under its 200-day average, 42 points behind the S&P 500 over 3 months
The CEO of Opal Fuels paid $17K out of pocket for Opal Fuels shares. 3 other people at Opal Fuels bought some too, in the same month.
Lately at Opal Fuels: it reported its results on Nov 9; the stock is down 16% in 30 days; insiders made 11 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Traded Nov 17, 2026 · largest single transaction ~$37K
Lately at Brc Group Holdings: it changed a top executive or board member on Nov 13; the stock is down 35% in 30 days; insiders made 3 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Nov 17, 2026~$37K · 12K sh @ $3.12
DetailsOfficial recordNov 17, 2026~$37K · 12K sh @ $3.12
DetailsOfficial recordInsider buying
3 insiders in a week, 2nd time since 2021Traded Nov 18 · filed the same day
Since the trade −3.3% · S&P 500 −5.5% · to Nov 20
Bought 57% below the 52-week high, RSI 27, 44% under its 200-day average, 37 points behind the S&P 500 over 3 months
A Neuropace director paid $104K out of pocket for Neuropace shares. 2 other people at Neuropace bought some too, in the same month.
Lately at Neuropace: the stock fell 37% in one session on Nov 13 around a company release; it reported its results on Nov 12; the stock is down 39% in 30 days.